Diuretics as initial treatment for essential hypertension
- PMID: 37873
- PMCID: PMC1429330
- DOI: 10.1111/j.1365-2125.1979.tb04689.x
Diuretics as initial treatment for essential hypertension
Abstract
1 In the United States, the thiazide diuretics are considered the cornerstone of all antihypertensive regimens for four reasons: by themselves, they are capable of controlling the blood pressure in 60-70% of the hypertensive population; they prevent the sodium retention produced by all other antihypertensive agents; they can be given once a day; and they are inexpensive. 2 Despite these advantages, the thiazide do cause hypokalaemia hyperuricaemia and hyperglycaemia. The incidence of hypokalaemia (K less than 3.0 mEq/l) is only 2-4%; the incidence of hyperuricaemia (uric acid greater than 10 mg per cent is 3-4%; and the incidence of hyperglycaemia is 1-2%. 3 The possibility that a beta-blocking agent combined with a thiazide diuretic might produce better BP control, prevent thiazide-induced abnormalities and exert a coronary prevention action with once daily administration would suggest that such a combination should be the ideal initial therapy for most patients with hypertension.
Similar articles
-
The use of diuretics in modern antihypertensive therapy.Acta Pharmacol Toxicol (Copenh). 1984;54 Suppl 1:79-87. doi: 10.1111/j.1600-0773.1984.tb03638.x. Acta Pharmacol Toxicol (Copenh). 1984. PMID: 6143473
-
Thiazide diuretics in hypertension.Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):805-14. doi: 10.3109/10641969909061010. Clin Exp Hypertens. 1999. PMID: 10423103 Review.
-
Diuretics in the treatment of hypertension.Am Pharm. 1978 May;18(5):34-9. doi: 10.1016/s0160-3450(15)32482-x. Am Pharm. 1978. PMID: 655123 No abstract available.
-
Biochemical consequences of diuretic therapy in hypertension.J Tenn Med Assoc. 1978 Oct;71(10):757-8. J Tenn Med Assoc. 1978. PMID: 723254 No abstract available.
-
[Advantages and disadvantages of diuretics and beta-blocking agents in the treatment of hypertension. Review of the literature].Acta Clin Belg. 1979;34(5):298-305. doi: 10.1080/22953337.1979.11718702. Acta Clin Belg. 1979. PMID: 44955 Review. French. No abstract available.
Cited by
-
The management of hypertension.Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):129S-142S. doi: 10.1111/j.1365-2125.1986.tb02862.x. Br J Clin Pharmacol. 1986. PMID: 3530297 Free PMC article. Review. No abstract available.
-
A study of the antihypertensive action of xipamide using ambulatory intra-arterial monitoring.Br J Clin Pharmacol. 1981 Sep;12(3):381-5. doi: 10.1111/j.1365-2125.1981.tb01230.x. Br J Clin Pharmacol. 1981. PMID: 7295468 Free PMC article.
-
Drug treatment of hypertension.Drugs. 1988;35 Suppl 6:40-52. doi: 10.2165/00003495-198800356-00006. Drugs. 1988. PMID: 3042360 Review.
-
Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.Eur J Clin Pharmacol. 1984;27(4):407-14. doi: 10.1007/BF00549586. Eur J Clin Pharmacol. 1984. PMID: 6394349 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources